Iressa® - pro.medicin.dk – information om medicin

Ikke-småcellet lungecancer, som udtrykker EGFR. Gefitinib bør kun anvendes, når behandlingen forestås af læger med særligt kendskab til maligne lidelser og deres behandling.

Iressa® - min.medicin.dk – information om medicin

Midlet skal anvendes med forsigtighed ved dårligt fungerende nyrer eller lever samt ved visse lungesygdomme. Ved begyndende tegn på hornhindebetændelse (fx tåreflåd, lysfølsomhed i øjet, uskarpt syn, røde øjne og øjensmerter) skal du straks kontakte sygehuset.

Gefitinib - Wikipedia

Gefitinib (ZD1839) (INN, / ɡ ɛ ˈ f ɪ t ɪ n ɪ b /, trade name Iressa) is a drug used for certain breast, lung and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells.

Iressa (gefitinib) Uses, Dosage, Side Effects - Drugs.com

Iressa is used in the treatment of non-small cell lung cancer. Learn about side effects, interactions and indications.

European Medicines Agency - Find medicine - Iressa

Iressa should not be used in people who may be hypersensitive (allergic) to gefitinib or any of the other ingredients. It must not be used in mothers who are breastfeeding. It must not be used in mothers who are breastfeeding.

Iressa® - Apoteket.dk

Det er vigtigt at informere lægen om alle de lægemidler, du tager. Epilepsimidler (carbamazepin, phenobarbital og phenytoin), antibiotikum (rifampicin) samt midler mod mavesår (syrepumpehæmmere, H2-blokkere) og syreneutraliserende middel kan nedsætte virkningen af Iressa®.

Iressa - FDA prescribing information, side effects and uses

Iressa is indicated for the first-line treatment of patients with or metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test [see Clinical Studies (14)].

Iressa Oral : Uses, Side Effects, Interactions, Pictures ...

How to use Iressa. Take gefitinib by mouth once daily, with or without food, or as directed. Medications which reduce or completely block stomach acid (e.g., proton pump inhibitors/PPIs, H2 blockers, antacids) may decrease the absorption of gefitinib.

Iresa Limited

Iresa are disappointed by Ofgem’s decision to give notice of their intention to extend the provisional order as we have made significant changes to improve the service we deliver to our customers.

Gefitinib – Wikipedia

Gefitinib (Handelsname Iressa, AstraZeneca) ist ein als Tablette einzunehmendes Medikament aus der Wirkstoffklasse der Tyrosinkinase-Inhibitoren. Die übliche Dosierung beträgt 250 mg täglich. Die übliche Dosierung beträgt 250 mg täglich.